Literature DB >> 16184202

Intrauterine growth restriction--diagnosis and management.

Collette Sheridan1.   

Abstract

BACKGROUND: Fetal growth disorders are an important cause of perinatal morbidity and mortality with long term health implications for the survivors of intrauterine growth restriction (IUGR). The accurate assessment of fetal growth during pregnancy is difficult, but recent advances have improved this important aspect of obstetric care with positive implications for antenatal patients and their babies.
OBJECTIVE: This article provides an overview of the detection of fetal growth problems in pregnancy, the determination of the likely cause, and the antenatal and intrapartum care of women with pregnancies identified as being affected by IUGR. The role of customised fetal growth assessment in the detection of IUGR is considered and followed by an outline of the appropriate monitoring and management of these pregnancies based on the underlying pathophysiology. DISCUSSION: Accurate assessment of fetal growth is improved by early clarification of gestational age and the use of customised fetal growth charts. Once infections and anomalies have been excluded, it is imperative to distinguish the healthy small fetus from the growth restricted fetus. While treatment options are limited, the optimal management of the IUGR affected fetus aims to achieve the delivery of the newborn in the best possible condition, balancing the risks of prematurity against those of continued intrauterine existence.

Entities:  

Mesh:

Year:  2005        PMID: 16184202

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  10 in total

Review 1.  Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries.

Authors:  Tatiana M Lanzieri; Sheila C Dollard; Stephanie R Bialek; Scott D Grosse
Journal:  Int J Infect Dis       Date:  2014-03-12       Impact factor: 3.623

2.  Diagnosis and management of Silver-Russell syndrome: first international consensus statement.

Authors:  Emma L Wakeling; Frédéric Brioude; Oluwakemi Lokulo-Sodipe; Susan M O'Connell; Jennifer Salem; Jet Bliek; Ana P M Canton; Krystyna H Chrzanowska; Justin H Davies; Renuka P Dias; Béatrice Dubern; Miriam Elbracht; Eloise Giabicani; Adda Grimberg; Karen Grønskov; Anita C S Hokken-Koelega; Alexander A Jorge; Masayo Kagami; Agnes Linglart; Mohamad Maghnie; Klaus Mohnike; David Monk; Gudrun E Moore; Philip G Murray; Tsutomu Ogata; Isabelle Oliver Petit; Silvia Russo; Edith Said; Meropi Toumba; Zeynep Tümer; Gerhard Binder; Thomas Eggermann; Madeleine D Harbison; I Karen Temple; Deborah J G Mackay; Irène Netchine
Journal:  Nat Rev Endocrinol       Date:  2016-09-02       Impact factor: 43.330

3.  STOX2 but not STOX1 is differentially expressed in decidua from pre-eclamptic women: data from the Second Nord-Trondelag Health Study.

Authors:  M H Fenstad; M P Johnson; M Løset; S B Mundal; L T Roten; I P Eide; L Bjørge; R K Sande; A K Johansson; T D Dyer; S Forsmo; J Blangero; E K Moses; R Austgulen
Journal:  Mol Hum Reprod       Date:  2010-07-19       Impact factor: 4.025

4.  Intrauterine growth retardation--small events, big consequences.

Authors:  Taimur Saleem; Nida Sajjad; Sanna Fatima; Nida Habib; Syed R Ali; Maqbool Qadir
Journal:  Ital J Pediatr       Date:  2011-09-07       Impact factor: 2.638

5.  Care-related factors associated with antepartal diagnosis of intrauterine growth restriction: a case-control study.

Authors:  Sinja Alexandra Ernst; Anna Reeske; Jacob Spallek; Knud Petersen; Tilman Brand; Hajo Zeeb
Journal:  BMC Pregnancy Childbirth       Date:  2014-10-31       Impact factor: 3.007

6.  Infant mortality and morbidity associated with preterm and small-for-gestational-age births in Southern Mozambique: A retrospective cohort study.

Authors:  Alberto L García-Basteiro; Llorenç Quintó; Eusebio Macete; Azucena Bardají; Raquel González; Arsenio Nhacolo; Betuel Sigauque; Charfudin Sacoor; María Rupérez; Elisa Sicuri; Quique Bassat; Esperança Sevene; Clara Menéndez
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

7.  Care-Related and Maternal Risk Factors Associated with the Antenatal Nondetection of Intrauterine Growth Restriction: A Case-Control Study from Bremen, Germany.

Authors:  Sinja Alexandra Ernst; Tilman Brand; Anna Reeske; Jacob Spallek; Knud Petersen; Hajo Zeeb
Journal:  Biomed Res Int       Date:  2017-04-04       Impact factor: 3.411

8.  Genetic disruption of the oncogenic HMGA2-PLAG1-IGF2 pathway causes fetal growth restriction.

Authors:  Walid Abi Habib; Frédéric Brioude; Thomas Edouard; James T Bennett; Anne Lienhardt-Roussie; Frédérique Tixier; Jennifer Salem; Tony Yuen; Salah Azzi; Yves Le Bouc; Madeleine D Harbison; Irène Netchine
Journal:  Genet Med       Date:  2017-08-10       Impact factor: 8.822

9.  Course of the sFlt-1/PlGF ratio in fetal growth restriction and correlation with biometric measurements, feto-maternal Doppler parameters and time to delivery.

Authors:  A Andrikos; D Andrikos; B Schmidt; C Birdir; R Kimmig; A Gellhaus; A Köninger
Journal:  Arch Gynecol Obstet       Date:  2021-08-25       Impact factor: 2.344

10.  Fundal height growth curve patterns of pregnant women with term low birth weight infants.

Authors:  Jirawan Deeluea; Supatra Sirichotiyakul; Sawaek Weerakiet; Suthit Khunpradit; Jayanton Patumanond
Journal:  Risk Manag Healthc Policy       Date:  2014-07-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.